BCRX: BioCryst Pharmaceuticals Inc

8.22 USD 0.03 (0.36%)

Sector: Atención Sanitaria Básica: US Dollar Divisa de beneficio: US Dollar

El tipo de cambio de BCRX de hoy ha cambiado un -0.36%. En este caso, el precio mínimo en el mercado ha alcanzado 8.12, mientras que el máximo ha alcanzado 8.39.

Siga la dinámica de la pareja de divisas BioCryst Pharmaceuticals Inc. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.

Gráfico a pantalla completa

BCRX News

Zacks 14:00 Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for
Zacks 14:00 BioCryst Pharmaceuticals (BCRX) Reports Next Week: Wall Street Expects Earnings Growth
Investing 17:32 BioCryst stock undervalued ahead of Q2 earnings, says RBC Capital
Investing 17:20 Citizens JMP downgrades Clearside Biomedical stock rating as company pauses R&D
Investing 11:46 Clearside Biomedical stock falls after announcing strategic alternatives exploration
Seeking Alpha 19:24 Astria: Betting On Navenibart In The Crowded HAE Arena
Investing 11:05 BioCryst Pharmaceuticals appoints Babar Ghias as CFO
Benzinga 14:41 BioCryst Just Ditched Its Europe Business — Here's Why Investors Are Cheering - BioCryst Pharma (NASDAQ:BCRX)
Investing 12:19 BioCryst stock rises after $264 million sale of European ORLADEYO business
Investing 11:04 BioCryst to sell European ORLADEYO business to Neopharmed for $264M
Investing 11:04 FDA extends review period for BioCryst pediatric drug application to December
Investing 11:09 BioCryst reports long-term efficacy of ORLADEYO in HAE treatment
Investing 11:06 Colombia approves BioCryst’s oral HAE treatment ORLADEYO
Investing 14:15 BioCryst at Goldman Sachs Conference: Strategic Growth and Profitability
Seeking Alpha 21:26 Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside
Investing 11:05 Netherlands approves BioCryst’s HAE drug ORLADEYO for reimbursement
Investing 11:36 biocryst pharmaceuticals extends cfo consulting agreement
Investing 11:32 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Investing 11:32 BioCryst to Present New Data at 2025 Meeting of the European Academy of Allergy and Clinical Immunology
Investing 11:06 BioCryst reports efficacy of HAE drug across age groups
Investing 13:44 Cantor Fitzgerald maintains overweight on Metsera shares
Investing 11:28 BioCryst to Present at Upcoming Investor Conferences
Investing 11:05 BioCryst reports ORLADEYO reduces severe HAE attack rates
Benzinga 21:29 BioCryst Pharmaceuticals Soars 23% In One Session - Here's Why It Surprised Investors - BioCryst Pharma (NASDAQ:BCRX)

Rango diario

8.12 8.39

Rango anual

6.01 11.31

Cierres anteriores: 8.09
Open: 8.25

Bid: 8.22
Ask: 8.52

Low: 8.12
High: 8.39

Volumen: 5.803 K

Cambio diario: -0.36%
Cambio mensual: -8.46%

Cambio a 6 meses: 6.48%
Cambio anual: 12.60%

30 julio, miércoles